Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1977 3
1978 3
1981 1
1982 1
1983 1
1984 1
1985 3
1986 4
1987 1
1988 5
1989 4
1990 4
1991 1
1992 4
1993 2
1994 12
1995 3
1996 13
1997 2
1998 11
1999 6
2000 11
2001 2
2002 10
2003 11
2004 14
2005 16
2006 8
2007 11
2008 16
2009 14
2010 12
2011 24
2012 20
2013 20
2014 26
2015 15
2016 14
2017 19
2018 12
2019 19
2020 18
2021 19
2022 14
2023 11
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

398 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Borderline epithelial tumor of ovary"
Page 1
Low-grade serous ovarian cancer: State of the science.
Slomovitz B, Gourley C, Carey MS, Malpica A, Shih IM, Huntsman D, Fader AN, Grisham RN, Schlumbrecht M, Sun CC, Ludemann J, Cooney GA, Coleman R, Sood AK, Mahdi H, Wong KK, Covens A, O'Malley DM, Lecuru F, Cobb LP, Caputo TA, May T, Huang M, Siemon J, Fernández ML, Ray-Coquard I, Gershenson DM. Slomovitz B, et al. Gynecol Oncol. 2020 Mar;156(3):715-725. doi: 10.1016/j.ygyno.2019.12.033. Epub 2020 Jan 20. Gynecol Oncol. 2020. PMID: 31969252 Review.
In January 2019, a group of basic, translational, and clinical investigators and patient advocates assembled in Miami, Florida, to discuss the current state of the science of low-grade serous carcinoma of the ovary or peritoneum-a rare ovarian cancer subtype that may arise …
In January 2019, a group of basic, translational, and clinical investigators and patient advocates assembled in Miami, Florida, to discuss t …
Trametinib versus standard of care in patients with recurrent low-grade serous ovarian cancer (GOG 281/LOGS): an international, randomised, open-label, multicentre, phase 2/3 trial.
Gershenson DM, Miller A, Brady WE, Paul J, Carty K, Rodgers W, Millan D, Coleman RL, Moore KN, Banerjee S, Connolly K, Secord AA, O'Malley DM, Dorigo O, Gaillard S, Gabra H, Slomovitz B, Hanjani P, Farley J, Churchman M, Ewing A, Hollis RL, Herrington CS, Huang HQ, Wenzel L, Gourley C. Gershenson DM, et al. Lancet. 2022 Feb 5;399(10324):541-553. doi: 10.1016/S0140-6736(21)02175-9. Lancet. 2022. PMID: 35123694 Free PMC article. Clinical Trial.
BACKGROUND: Low-grade serous carcinoma of the ovary or peritoneum is characterised by MAPK pathway aberrations and its reduced sensitivity to chemotherapy relative to high-grade serous carcinoma. ...Eligible patients were aged 18 years or older with recurrent low-grade ser …
BACKGROUND: Low-grade serous carcinoma of the ovary or peritoneum is characterised by MAPK pathway aberrations and its reduced sensit …
The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory.
Kurman RJ, Shih IeM. Kurman RJ, et al. Am J Surg Pathol. 2010 Mar;34(3):433-43. doi: 10.1097/PAS.0b013e3181cf3d79. Am J Surg Pathol. 2010. PMID: 20154587 Free PMC article.
Efforts at early detection and new therapeutic approaches to reduce mortality have been largely unsuccessful, because the origin and pathogenesis of epithelial ovarian cancer are poorly understood. Despite numerous studies that have carefully scrutinized the ovaries …
Efforts at early detection and new therapeutic approaches to reduce mortality have been largely unsuccessful, because the origin and pathoge …
Borderline Brenner Tumor: A Review of the Literature.
Zheng R, Heller DS. Zheng R, et al. Arch Pathol Lab Med. 2019 Oct;143(10):1278-1280. doi: 10.5858/arpa.2018-0285-RS. Epub 2019 Feb 19. Arch Pathol Lab Med. 2019. PMID: 30779594 Free article. Review.
Brenner tumors arise from ovarian epithelium, accounting for approximately 5% of benign ovarian epithelial tumors. The World Health Organization classification groups them into benign, borderline, and malignant on the basis of proliferation and invasiveness, and …
Brenner tumors arise from ovarian epithelium, accounting for approximately 5% of benign ovarian epithelial tumors. The World Health O …
Brenner Borderline Ovarian Tumor: A Case Series and Literature Review.
Ricotta G, Maulard A, Genestie C, Pautier P, Leary A, Chargari C, Candiani M, Morice P, Gouy S. Ricotta G, et al. Ann Surg Oncol. 2021 Oct;28(11):6714-6720. doi: 10.1245/s10434-021-09879-y. Epub 2021 Mar 25. Ann Surg Oncol. 2021. PMID: 33768396 Review.
BACKGROUND: Most frequent borderline ovarian tumors are serous and mucinous subtypes. Less frequent borderline diseases are endometrioid, clear-cell, and Brenner tumors (BBOT). ...Median follow-up was 60 months (range 7-118 months). One patient developed a recurrenc …
BACKGROUND: Most frequent borderline ovarian tumors are serous and mucinous subtypes. Less frequent borderline diseases are en …
Borderline ovarian tumors: Guidelines from the French national college of obstetricians and gynecologists (CNGOF).
Bourdel N, Huchon C, Abdel Wahab C, Azaïs H, Bendifallah S, Bolze PA, Brun JL, Canlorbe G, Chauvet P, Chereau E, Courbiere B, De La Motte Rouge T, Devouassoux-Shisheboran M, Eymerit-Morin C, Fauvet R, Gauroy E, Gauthier T, Grynberg M, Koskas M, Larouzee E, Lecointre L, Levêque J, Margueritte F, Mathieu D'argent E, Nyangoh-Timoh K, Ouldamer L, Raad J, Raimond E, Ramanah R, Rolland L, Rousset P, Rousset-Jablonski C, Thomassin-Naggara I, Uzan C, Zilliox M, Daraï E. Bourdel N, et al. Eur J Obstet Gynecol Reprod Biol. 2021 Jan;256:492-501. doi: 10.1016/j.ejogrb.2020.11.045. Epub 2020 Nov 20. Eur J Obstet Gynecol Reprod Biol. 2021. PMID: 33262005
It is recommended to classify Borderline Ovarian Tumors (BOTs) according to the WHO classification. ...It is recommended that a systematic clinical examination be carried out during follow-up of a treated BOT (Grade B). If the determination of tumor markers is norma …
It is recommended to classify Borderline Ovarian Tumors (BOTs) according to the WHO classification. ...It is recommended that a syste …
Prognostic indicators in ovarian serous borderline tumours.
Malpica A, Longacre TA. Malpica A, et al. Pathology. 2018 Feb;50(2):205-213. doi: 10.1016/j.pathol.2017.12.001. Epub 2017 Dec 28. Pathology. 2018. PMID: 29289348 Review.
There have been great strides in our understanding of the serous group of borderline and malignant pelvic epithelial neoplasms in the past decade. While most serous borderline tumours have a favourable prognosis, recurrences and progression to carcinom …
There have been great strides in our understanding of the serous group of borderline and malignant pelvic epithelial neopla …
How and where to expect endosalpingiosis intraoperatively.
Burla L, Kalaitzopoulos DR, Mrozek A, Eberhard M, Samartzis N. Burla L, et al. Fertil Steril. 2022 Feb;117(2):461-462. doi: 10.1016/j.fertnstert.2021.11.016. Epub 2022 Jan 2. Fertil Steril. 2022. PMID: 34986982 Free article.
Endometriosis was associated in 53.2 % (n = 41) and malignancies in 28.6% (n = 22, 7 endometrial cancers, 1 uterine carcinosarcoma, 8 borderline ovarian tumors, 5 epithelial ovarian cancers, and 1 yolk sac tumor of the ovary). ...
Endometriosis was associated in 53.2 % (n = 41) and malignancies in 28.6% (n = 22, 7 endometrial cancers, 1 uterine carcinosarcoma, 8 bor …
Morphologic, Immunophenotypic, and Molecular Features of Epithelial Ovarian Cancer.
Ramalingam P. Ramalingam P. Oncology (Williston Park). 2016 Feb;30(2):166-76. Oncology (Williston Park). 2016. PMID: 26892153 Free article. Review.
Epithelial ovarian cancer comprises a heterogeneous group of tumors. ...Less common are transitional cell tumors, including transitional cell carcinoma and malignant Brenner tumor. While in the past these subtypes were grouped together and designated as epithelia …
Epithelial ovarian cancer comprises a heterogeneous group of tumors. ...Less common are transitional cell tumors, including transitio …
Progression of Cystadenoma to Mucinous Borderline Ovarian Tumor in Young Females: Case Series and Literature Review.
Beroukhim G, Ozgediz D, Cohen PJ, Hui P, Morotti R, Schwartz PE, Yang-Hartwich, Vash-Margita A. Beroukhim G, et al. J Pediatr Adolesc Gynecol. 2022 Jun;35(3):359-367. doi: 10.1016/j.jpag.2021.11.003. Epub 2021 Nov 27. J Pediatr Adolesc Gynecol. 2022. PMID: 34843973 Review.
MAIN OUTCOME MEASURES: Clinical presentation, preoperative characteristics, surgical technique, histology, tumor stage, treatment, progression, outcome, and rate of recurrence. ...Two of the 3 patients were initially diagnosed with a mucinous cystadenoma and had recurrence …
MAIN OUTCOME MEASURES: Clinical presentation, preoperative characteristics, surgical technique, histology, tumor stage, treatment, pr …
398 results